New Insights into Healthcare Costs for Children with Autism Spectrum Disorder
A recent study reveals that families with children undergoing autism treatment face nearly ten times higher healthcare costs, highlighting the significant financial burden associated with ASD management.
Recent research sheds light on the significant healthcare expenses faced by families with children diagnosed with autism spectrum disorder (ASD). The study, based on a nationally representative survey from 2018 to 2022, reveals that families with a child undergoing treatment for ASD incur nearly ten times higher healthcare costs compared to those without ASD treatment. Specifically, families with treated ASD reported average total expenditures of $20,122, in contrast to $2,201 for children without ASD treatment. Notably, up to 70% of these costs for children with treated ASD were directly related to ASD-specific care, although this proportion tended to decrease with age.
Autism spectrum disorder is a neurodevelopmental condition that impacts brain development, influencing social interactions, communication, behaviors, and interests. Symptoms often become evident before age three, including difficulties with social engagement and repetitive behaviors.
The survey also highlighted gender disparities, with treated ASD being three times more common among boys than girls. Additionally, the financial burden varies based on insurance type and socioeconomic status; children with public insurance and families living below the poverty line tend to have lower healthcare spending than those with private insurance and higher-income families.
In terms of healthcare utilization, outpatient visits constituted the largest portion of expenditures at 51% ($10,279), followed by home health care at 36% ($7,168). These costs were substantially higher than those for children without ASD, where outpatient expenses averaged $1,101 and home health care costs averaged $102. The analysis underscores the considerable financial impact of ASD treatment on families, particularly in specific areas of care.
It's important to note that expenses related to behavioral treatments provided in school settings and institutions were not included in this analysis. Additionally, about one-third of children with a diagnosis of ASD are not currently receiving treatment. Various federal and local agencies offer support to families, including early intervention services.
For more on autism spectrum disorder, visit the CDC's site at https://www.cdc.gov/autism/index.html.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Erythritol's Potential Impact on Brain Blood Vessels and Stroke Risk
New scientific research suggests that erythritol, a popular sugar substitute, may impair brain blood vessel function and elevate stroke risk. Learn about the latest findings on this widely used additive.
Using a Game to Combat Vaccine Misinformation: Innovative Approach Shows Promise
A new browser game, Bad Vaxx, demonstrates promising results in helping the public distinguish credible vaccine information from misinformation, aiming to strengthen immunity against health falsehoods.
Repurposing Decades-Old Drug Oxybutynin for Mitochondrial Disease Treatment
Researchers have discovered that oxybutynin, a decades-old drug used for bladder disorders, may be repurposed to treat mitochondrial diseases by enhancing cellular energy pathways. This promising research opens new avenues for combating these severe genetic disorders.
Balancing Risks and Benefits in Children's Play Environments for Healthy Development
A new assessment tool developed by researchers at the University of Technology Sydney helps balance safety and developmental benefits in children's play environments, promoting healthy growth through controlled risk-taking.